Stockreport

Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

 (DMRA) 
PDF -- DMR-001 on track for IND or CTA submission in mid-2026, with two clinical proof-of-concept datasets expected beginning mid-2027 -- -- Strong financial position with [Read more]